Patents Assigned to Aspect Pharmaceuticals LLC
  • Publication number: 20090130027
    Abstract: Embodiments of the present invention are directed to compositions and methods for the treatment of purpura. Preferred compositions comprise an ? adrenergic receptor agonist selected from selective ?1 adrenergic receptor agonist, selective ?2 adrenergic receptor agonist, non-selective ?1/?2 adrenergic receptor agonist, agents with ?2 adrenergic receptor agonist activity and combinations thereof, in a pharmaceutically acceptable carrier in order to treat and improve the cosmetic appearance of hemorrhagic (purpuric) lesions in the skin.
    Type: Application
    Filed: November 17, 2008
    Publication date: May 21, 2009
    Applicant: Aspect Pharmaceuticals LLC
    Inventors: Stuart D. Shanler, Andrew Ondo